Here's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings

Inspire Medical Systems (INSP) reported Q3 2026 revenue of $206.7 million, down 7.9% year-over-year, though it beat consensus estimates by 1.17%. EPS of $0.14 significantly exceeded expectations of $0.10 (+40%), but declined from $0.38 a year ago. U.S. revenue fell 7.9% to $197.49 million, while international revenue declined 8.9% to $9.21 million. The stock has been assigned a Zacks Rank #4 (Sell) rating.